TELA Bio, Inc. Pre-Tax Income
TELA Bio, Inc. (TELA) reported Pre-Tax Income of -$11.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-11
- TELA Bio, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was -$11.20M.
- TELA Bio, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was -$12.21M.
- TELA Bio, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was -$8.90M.
- TELA Bio, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was -$8.60M.
- TELA Bio, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was -$38.60M.
- TELA Bio, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$37.98M.
- TELA Bio, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$46.66M.
- TELA Bio, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$44.30M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$11.20M 10-Q · filed 2026-08-11 | -$23.41M 10-Q · filed 2026-08-11 | -$32.31M derived: sum of 3 quarters · filed 2026-08-11 | -$40.91M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$12.21M 10-Q · filed 2026-05-13 | -$21.11M derived: sum of 2 quarters · filed 2026-05-13 | -$29.71M derived: sum of 3 quarters · filed 2026-05-13 | -$39.60M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$8.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$17.50M derived: sum of 2 quarters · filed 2026-03-25 | -$27.39M derived: sum of 3 quarters · filed 2026-08-11 | -$38.60M 10-K · filed 2026-03-25 |
| 2025-09-30 | -$8.60M 10-Q · filed 2025-11-14 | -$18.49M derived: sum of 2 quarters · filed 2026-08-11 | -$29.70M 10-Q · filed 2025-11-14 | -$39.06M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$9.89M 10-Q · filed 2026-08-11 | -$21.10M 10-Q · filed 2026-08-11 | -$30.45M derived: sum of 3 quarters · filed 2026-08-11 | -$40.83M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$11.21M 10-Q · filed 2026-05-13 | -$20.56M derived: sum of 2 quarters · filed 2026-05-13 | -$30.94M derived: sum of 3 quarters · filed 2026-05-13 | -$43.54M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$9.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$19.72M derived: sum of 2 quarters · filed 2026-03-25 | -$32.32M derived: sum of 3 quarters · filed 2026-03-25 | -$37.98M 10-K · filed 2026-03-25 |
| 2024-09-30 | -$10.37M 10-Q · filed 2025-11-14 | -$22.97M derived: sum of 2 quarters · filed 2025-11-14 | -$28.63M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$12.60M 10-Q · filed 2025-08-11 | -$18.26M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | -$5.66M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$46.66M 10-K · filed 2026-03-25 | |||
| 2022-12-31 | -$44.30M 10-K · filed 2025-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |